Lisata Therapeutics, Inc. (LSTA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.16M |
| Enterprise Value | 201,820 |
| P/E Ratio | -0.64 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 94.61 |
| Price/Book Ratio | 1.16 |
| Enterprise/Revenue | -9.82 |
| Enterprise/EBITDA | 0.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -146.21 |
| Operating Margin | -164.27 |
AD
Management Effectiveness
| Return On Assets | -1.33 |
| Return On Equity | -1.14 |
Income Statement
| Revenue | 170,000 |
| Revenue/Share | 0.01 |
| Gross Profit | 24,000 |
| EBITDA | -17.4M |
| Net Income | -16.59M |
| Diluted EPS | -1.91 |
Balance Sheet
| Total Cash | 10.44M |
| Total Cash/Share | 1.15 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.69 |
| Book Value Per Share | 0.88 |
Price History
| 52-Week Change | -56.25 |
| 52-Week High | 5.07 |
| 52-Week Low | 0.96 |
| Moving Average 50 Days | 1.41 |
| Moving Average 200 Days | 3.03 |
Statistics
| Average Volume | 299,995 |
| Shares Outstanding | 9.01M |
| % Held by Institutions | 13.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 15, 2022 |
AD
